Erectile dysfunction decisions — 2025

The Board remands the claim for service connection of erectile dysfunction to properly adjudicate it, as a medical opinion is needed to address its relationship with the Veteran's service-connected disabilities.

The Board grants service connection for erectile dysfunction with left epididymal cyst as secondary to the Veteran's service-connected hypertension.

The Board remands the claim for service connection of erectile dysfunction to correct pre-decisional duty to assist errors.

The Board denied the veteran's claims for an initial compensable rating for ED with low sperm count and service connection for a low back disability, to include mild degenerative disc disease of the lumbosacral spine.

The Board denied an initial compensable rating for erectile dysfunction and remanded the claim for service connection for hypertension, to include as secondary to PTSD.

The Board denied earlier effective dates for increased ratings and service connection claims, as the evidence did not show a factually ascertainable increase in disability or entitlement to benefits prior to August 26, 2022.

The Board denied service connection for prostate cancer and erectile dysfunction, finding no evidence linking the disabilities to the Veteran's active service.

The Board granted a 40 percent disability rating for residuals of prostate cancer status post radical prostatectomy, as the Veteran's symptoms most closely approximate those required for that rating.

The Board denied the Veteran's claims for a compensable rating for erectile dysfunction and a higher disability evaluation for PTSD with recurrent depressive disorder, as well as remanded the issue of entitlement to a total disability rating based on individual unemployability.

The Board granted service connection for diabetes mellitus, type II, hypertension, and prostate cancer as due to exposure to herbicides. It also granted service connection for erectile dysfunction, nephropathy, bilateral lower extremity peripheral neuropathy, bilateral upper extremity peripheral neuropathy, and diabetic retinopathy as secondary to the already service-connected conditions of diabetes mellitus or prostate cancer.

The Veteran's service-connected disabilities have rendered him unable to secure or follow substantially gainful employment from August 11, 2023.

The Board granted service connection for tinnitus and bilateral visual discomfort, bilateral dry eye syndrome, and bilateral chronic allergic conjunctivitis but denied service connection for bilateral hearing loss and a fatigue disorder. The claims for increased ratings were also denied.

The Board granted service connection for generalized anxiety disorder and fasciculations and muscle spasms, but denied service connection for erectile dysfunction and urinary urgency and frequency disorder. The claim for bilateral pes planus was remanded.

The Board granted service connection for PTSD and erectile dysfunction, but denied service connection for headaches, left hand disability, left knee disability, left shoulder disability, right foot disability, right arm/shoulder disability, diabetes, and individual unemployability. The claim for service connection for a psychiatric disorder was granted.

The Board granted service connection for left side macroadenoma and its secondary conditions of erectile dysfunction, hypogonadism, and hypopituitarism.

The Board granted service connection for erectile dysfunction, a skin disability (tinea pedis), and rhinitis. Service connection was denied for sinusitis, irritable bowel syndrome, shortness of breath, and an anxiety condition.

The Board granted service connection for erectile dysfunction as secondary to the Veteran's service-connected prostate cancer and dismissed the appeals for service connection for radical prostatectomy with residuals and bladder cancer, which are now moot due to an earlier grant of service connection.

The Board granted earlier effective dates of December 21, 2021, for the awards of service connection for prostate cancer with urinary frequency, erectile dysfunction, and special monthly compensation based on loss of use of creative organ.

The Board granted an initial 100 percent rating for Parkinson's disease with major neurocognitive disorder and a 100 percent rating for loss of use of both feet and hands from June 7, 2021. The other claims were denied.

The Board remands the claims for service connection for erectile dysfunction, chronic kidney disease, migraine headaches, and a compensable rating for seborrheic dermatitis to obtain new medical opinions.